Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Clinical Pharmacology and Therapeutics|November 1, 2013
Novel immunomodulatory approaches for the management of multiple sclerosisO H Kantarci, I Pirko, M RodriguezMultiple Sclerosis (Houndmills, Basingstoke, England)|August 12, 2009
Multiple sclerosis risk in radiologically uncovered asymptomatic possible inflammatory-demyelinating diseaseA Siva, S Saip, A Altintas, et al.Journal of Neuroimmunology|April 1, 2000
Association of a myeloperoxidase promoter polymorphism with multiple sclerosisO H Kantarci, E J Atkinson, D D Hebrink, et al.Journal of Neuroimmunology|May 18, 2000
Association of two variants in IL-1beta and IL-1 receptor antagonist genes with multiple sclerosisO H Kantarci, E J Atkinson, D D Hebrink, et al.Journal of Neurology|April 4, 2001
Behçet's disease: diagnostic and prognostic aspects of neurological involvementA Siva, O H Kantarci, S Saip, et al.Journal of Neuroimmunology|November 6, 2001
Genetic variation in the transforming growth factor beta1 gene in multiple sclerosisB G Weinshenker, D Hebrink, O H Kantarci, et al.AJNR. American Journal of Neuroradiology|April 28, 2018
Dark Rims: Novel Sequence Enhances Diagnostic Specificity in Multiple SclerosisJ-M Tillema, S D Weigand, M Dayan, et al.Alimentary Pharmacology & Therapeutics|October 29, 2014
Idiopathic inflammatory demyelinating disease of the central nervous system in patients with inflammatory bowel disease: retrospective analysis of 9095 patientsK M De Felice, M Novotna, F T Enders, et al.Neurology|July 26, 2006
Men transmit MS more often to their children vs women: the Carter effectO H Kantarci, L F Barcellos, E J Atkinson, et al.Neurology|February 25, 2009
Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disordersS M Magaña, M Matiello, S J Pittock, et al.Pageof 2